Osaic Holdings’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEO
NCM
CCC
ACM
OIA
AIC
KCM
Osaic Holdings's ABEO Position: Q2 2026 in Review
Osaic Holdings reduced its Abeona Therapeutics (ABEO) stake by 4.9% in Q2 2026, selling an estimated $384 and leaving 1,361 shares worth $8.41K. The position accounts for ﹤0.01% of the portfolio, ranked #6700.
Osaic Holdings first reported a position in ABEO in Q1 2021 and has held it in 22 quarters since. The position peaked at $88.4K in Q3 2024. 127 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.
- Osaic Holdings held 1,361 shares of Abeona Therapeutics worth $8.41K as of Q2 2026.
- Osaic Holdings sold 70 Abeona Therapeutics shares in Q2 2026, an estimated $384.
- Abeona Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6700 holding.
- Osaic Holdings first reported a position in Abeona Therapeutics in Q1 2021 and has held it in 22 quarters since.
- Osaic Holdings's Abeona Therapeutics position peaked at $88.4K in Q3 2024.
- 127 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.